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Abstract
Background: Recent studies have revealed a low measles vaccination (MV) rate in the Republic of Guinea-Bissau (West Africa)
that has not increased in accordance with the increasing coverage of other vaccinations. Measles is the deadliest of all childhood
rash/fever illnesses and spreads easily, implying that if the vaccination coverage is declining there is a significant risk of new
measles outbreaks [27]. Meanwhile, mobile health (mHealth; the use of mobile phones for health interventions) has generated
much enthusiasm, and shown potential in improving health service delivery in other contexts.
Objective: The aim of this study is to evaluate the efficiency of mHealth as a tool for improving MV coverage while contributing
to the mHealth evidence base.
Methods: This study will take place at three health centers in different regions of Guinea-Bissau. Participants, defined as mothers
of the children receiving the MV, will be enrolled when they arrive with their children at the health center to receive the Bacillus
Calmette-Guérin vaccination, usually within one month of the child’s birth. Enrolment will continue until a study population of
990 children has been reached. The participants will be randomly assigned to a control arm or one of two intervention arms. Each
of the three groups will have 330 participants, distributed equally between health centers. Participants in the first intervention
arm will receive a scheduled short message service (SMS) text message reminding them of the MV. Participants in the second
intervention arm will receive a voice call in addition to the SMS message, while the control arm will receive no interventions.
The MV is scheduled to be administered at 9 months of age. Although the vaccine would still be effective after 12 months, local
policy in Guinea-Bissau prevents children aged >12 months from receiving the vaccination, and thus the study will follow-up
with participants after the children reach 12 months of age. Children who have not yet received the MV will be offered vaccination
by the project group.
Results: The study will analyze the efficiency of the intervention by determining its overall effect on MV coverage and timeliness
when children reach 12 months of age. The main analysis will be stratified by intervention group, health center, level of education,
ethnic group, and role of the person receiving the text messages (eg, mother, father, other family member). Secondary outcomes
include the average number of health center visits (with intention to obtain the MV) required before successful administration.
Conclusions: Despite the rapid proliferation of mHealth projects, only a small number have been evaluated in terms of direct
links to health outcomes. This gap in knowledge requires solid evidence on which policy-makers can base decisions. This study
aims to produce significant knowledge about mHealth implementation within a Sub-Saharan context while creating data-supported
evidence.
Trial Registration: Clinicaltrials.gov: NCT02662595; https://clinicaltrials.gov/ct2/show/NCT02662595 (Archived by WebCite
at http://www.webcitation.org/6jH8YiSjY)
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Introduction
Background
The use of mobile phones as a tool for health interventions
(mHealth) has shown significant potential worldwide, and has
been used in low income settings. The benefits of such
interventions include low start-up costs [1] and the possibility
of reaching a great number of people. According to recent
reports [2,3], a number of mHealth initiatives have already been
conducted around the world. Despite these advances, mHealth
has untapped potential, especially in the African region, where
the number of such initiatives is the lowest in the world [3].
Although the rapid proliferation of mHealth projects has
generated enthusiasm [4], more evidence establishing their
efficacy and effectiveness is needed [3,5,6].
Current studies from the International Network for the
Demographic Evaluation of Populations and Their Health
(INDEPTH) and the Global Alliance for Vaccines and
Immunization (GAVI) reveal a low measles vaccination (MV)
rate in Guinea-Bissau that has not increased in accordance with
the increasing coverage of other vaccinations. In 2014 the United
Nations International Children's Emergency Fund (UNICEF)
estimated that MV coverage among children 12-23 months of
age in Guinea-Bissau was 64% [7], a number that has steadily
decreased since 2004 [8].
Meanwhile, other studies have shown that mHealth interventions
can be efficient in increasing awareness and demand for health
services [9-14]. An important prerequisite for mHealth projects
to be successful is access to mobile phones, which has grown
rapidly in many developing countries. According to the World
Development Indicators provided by The World Bank, it was
estimated that in 2013 there were 74 cellular subscriptions per
100 people in Guinea-Bissau (compared to 45 in 2011 and 63
in 2012) [15].
Measles is the deadliest of all childhood rash/fever illnesses and
spreads easily, implying that if the MV coverage is declining
[16] there is a significant risk of new measles outbreaks [17].
Recent reports from World Health Organization conclude that
increased activities are needed to resume progress towards the
2015 Millennium Development Goals of measles control and
elimination [18,19]. In addition, recent studies have lead the
Strategic Advisory Group of Experts on Immunization to suggest
that MV is associated with possible beneficial effects on
all-cause mortality [20]. Interventions that enhance the
timeliness and coverage of MV are therefore likely to have a
great beneficial impact on child health. Thus, we suggest an
mHealth intervention to increase MV coverage by sending
vaccination reminders by short message service (SMS) texts to
mothers before their child’s scheduled MV. While this
intervention aims at increasing awareness amongst mothers, it
also presents potential benefits regarding the supply of MVs.
Current policies in Guinea-Bissau require a minimum number
of children to be present before a vial of vaccine can be opened,
and since the health centers typically only administer
vaccinations one or two days per week, mothers will often the
be sent home and told to return a different day. This intervention
has the potential to coordinate the vaccination visits and help
ensure that enough children are present for the health centers
to open a vial of vaccines on a given day, and ensure that
mothers arrive on the correct day at the health centers.
Studies from the INDEPTH Network and GAVI have
demonstrated that rural regions have particularly low MV
coverage, so this intervention will focus on the rural regions of
Tombali, Gabu, and Cacheu in the Southern, Eastern, and
Northern Guinea-Bissau, respectively.
Objectives
The primary objective of this intervention is to enable a
beneficial impact on child health by improving timeliness and
coverage of MVs using simple and cost-efficient methods.
Specifically, the study aims to investigate whether a mobile
phone targeted reminder system can be used in the context of
rural Guinea-Bissau, and what effect this intervention can be
expected to have, as well as potential obstacles and barriers to
implementation.
Methods
Trial Design
This study is designed as a multi-site, three arm, parallel
randomized controlled trial (RCT). Participants will be
randomized to either one of two intervention arms (one receiving
an SMS reminder, the other receiving the SMS reminder and
an additional voice call) or a control arm (no intervention) with
a 1:1:1 allocation ratio (Figure 1).
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Figure 1. Study flow.
Informed Consent Forms
Informed consent will be obtained for all study participants
before enrollment. The study will be described to the potential
participants by trained study workers at the health centers. The
project description will be explained in the preferred language
of either Portuguese or Creole. After the project has been
explained, the potential participant will be asked a number of
questions related to the project to ensure adequate understanding,
and informed consent forms will be signed.
Randomization and Blinding
Three randomization sequences (one per health center) were
generated using a software algorithm. The randomization
sequences are only accessible for the central project group, and
will be used when the central project assistant is adding study
participants to the scheduling system and delivering phone
messages. Participant allocation is concealed to the study
assistants at the health facilities, and will only be revealed during
the follow-up interview when, and if, the participants come to
the health facility to receive MVs.
Setting and Participants
Study participants, defined as mothers of the children receiving
the MV, will be enrolled at one of three selected health facilities
when their children receive their first vaccination, usually the
Bacillus Calmette-Guérin vaccine, which is administered shortly
after birth. The study will be explained to the mothers by the
health workers in the local language (Portuguese Creole), and
pending their informed consent, the mothers will be enrolled in
the study. Enrollment is completed by the health worker, who
will take note of the participant’s phone number(s), date of birth,
and the baby’s name. A sticker with a unique study identification
number will be placed on the child’s vaccination card to indicate
that this child is participating in the study.
The inclusion criteria for enrollment in the study are that the
participant has access to a cell phone (either her own phone or
the phone of a household member or community contact) and
that she lives in the uptake area of the health center.
A study assistant will collect information regarding the
participant, including age, ethnic group/primary language, and
level of education. This information will be entered into a digital
questionnaire using an Android device. The data will be
successively transferred to a central information technology
(IT) system, where a central study assistant will randomize
participants and enter the data into the system responsible for
scheduling and sending SMS messages, and creating call-lists
for the participants scheduled to receive verbal messages.
The enrollment period for this study component will continue
until a study population of 990 children (see sample size
calculation below) has been reached (total enrollment time is
estimated to be approximately 6 months). We will follow up
after children reach 12 months of age, since MVs are scheduled
to be administered at 9 months of age, and local policy in
Guinea-Bissau prevents children aged >12 months from
receiving the MV. Thus, this component of the intervention is
estimated to last no longer than 18 months.
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Intervention
The intervention being evaluated is a cell phone reminder and
coordination system, which seeks to coordinate potential
recipients of MV with MV opportunities (ie, days in which MV
is administered either at their local health center, or at a relevant
outreach day). Participants allocated to intervention groups will
receive two SMS text reminders in the local language of
Portuguese Creole. The first message will be delivered three
days before the suitable MV opportunity, and the second will
be sent one day before. If the participant is allocated to also
receive a phone call, a project worker will call the supplied
phone number two days before the MV opportunity.
SMS messages are active in the cell phone network for 24 hours,
after which the delivery attempt will be considered failed. If the
delivery attempt of a first message fails (ie, three days before
MV opportunity), the message will be redelivered. If delivery
of the second message fails (ie, one day before MV opportunity),
it will not be redelivered due to time rendering it irrelevant. If
a phone call fails it will be reattempted two times: once on the
same day, and a final attempt on the day before MV opportunity.
We will register all failed message delivery attempts and account
for these in the subsequent analysis.
If several phone numbers are supplied, SMS texts will be sent
to all phone numbers. Voice calls will made to one number, and
if the call to the first number is not successful, the second
number will be attempted, and so on. Voice calls, like the SMS
texts, will be made in the Creole language.
If a study participant does not arrive at the MV opportunity, or
if the MV opportunity is cancelled or unavailable for any reason,
the study participant will receive a new set of messages/voice
calls at the next relevant MV opportunity, assuming the child
is still eligible (ie, child is 9-12 months of age). The new set of
messages will be delivered regardless of whether earlier delivery
attempts for the participant failed.
Follow-Up
When MVs are given in one of the selected health centers, the
participants will be registered in the system as having received
the vaccination at the given date. The study assistant will also
take note of a set of follow-up questions concerning the
participants’ motivation for receiving the vaccination as well
as a final question as to whether the participant received and
understood the text reminder/voice call. The answers to these
questions will eliminate the blinding of within the study, since
the participants’ answers will reveal their allocation group. In
addition, data regarding price of phone call and time spent per
phone call will be collected after each call, and analyzed in
terms of cost effectiveness.
A qualitative analysis will be done when children reach 13
months of age, for all participants not registered as having
received MVs. The analysis will be based on phone interviews
to determine the main reasons for not receiving the vaccine, and
it will be registered whether the child has received MV at a
different location, moved out of the area, or died. All of these
participants will be offered MVs for their children.
A selection of participants from each intervention group
(n=10-15), who registered their children as having received the
MV, will be visited by a study assistant in order to conduct a
face-to-face follow-up interview. These interview will focus on
the participants’ perception of the intervention message and the
overall experience of the intervention. Data collection will rely
on digital questionnaires filled out by project assistants during
house visits. Difficulty with logistics (ie, locating and visiting
the participants) explain the relatively small number of
participants selected for this analysis.
Location and Duration of the Project
In coordination with the Ministry of Health in Guinea-Bissau,
three participating health centers will be selected in the
aforementioned regions of rural Guinea-Bissau. The centers
will be selected based on the size of the health center (ie, the
capacity for enrolling enough study participants during a period
of six months), distance to neighboring health centers, mobile
cell network coverage, and current level of outreach/other
studies.
The first component was carried out in the period from October,
2015 to March, 2016. The second component is scheduled to
begin in the first quarter of 2016 and end in the third quarter of
2017 (18 months).
Development of Reminder Content and Timing
In order to assess the intervention context, and determine the
optimal timing and content of the messages to be used in the
RCT, a qualitative analysis will be conducted. The analysis will
be based on field visits in the rural areas to observe the context
for the intervention, including the daily routines for mothers
with children aged 6-12 months and their usage of mobile
technology. In addition to these observations, a number of
semistructured qualitative interviews will be conducted to
acquire knowledge about what time of day a message would be
preferred, and potential cultural barriers preventing the delivery
of messages to household members or neighbors (if the mother
does not own a phone).
During the interview, the interviewee will be presented with
one of three different versions of the intervention message, and
asked questions to evaluate their understanding:
1. A very brief description of measles infection and the reasons
for vaccination, inspired by a post card MV reminder
intervention that was implementing using the health belief model
[21].
2. A shorter and more imperative message telling the participant
to go to the health center to receive the MV.
3. A verbal message read to the interviewee by the interviewer.
The messages will be personalized with the baby’s name and
the name of the relevant health center.
All of the messages will be presented in two formats, depending
on whether the message is to be delivered directly to the
participant’s phone or via the phone of a household
member/neighbor. The indirect message variants will be
evaluated by presenting them to nearby household members
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and assessing their understanding and willingness to relay the
message.
Technical Implementation
Building on the efforts of UNICEF, the technical aspects of the
project will be based on the open source IT system, RapidSMS.
This system is well documented, and has previously been applied
successfully in comparative interventions in Kenya and Rwanda
[10,22]. The system is customizable and will be adapted to the
context of this study. The RapidSMS system will generate
reports on SMS texts that failed to be delivered to the recipient
(eg, due to cell phone being off for longer periods of time, or a
changed phone number). These texts will be delivered again.
To enable digital data collection using tablets/phones, an adapted
version of Open Data Kit will be used.
To enable capacity building, and thus increase the chances of
the system being implemented if the intervention is deemed
successful, the technical implementation will be done in close
coordination with technical personnel from the national Ministry
of Health.
Results
In order to evaluate mHealth as a viable means of increasing
MV coverage and timeliness, an RCT will be conducted. The
mHealth intervention will be evaluated using the outcomes in
Textbox 1.
Textbox 1. Outcome measures of the randomized control trial.
• Primary outcome A:
MV coverage at 12 months of age. Difference in MV coverage at 12 months of age between the intervention groups and the control group.
• Secondary outcome B:
Timeliness. Difference in timeliness of MVs administered, measured as median age of vaccinated children.
• Secondary outcome C:
Average number of visits to the health center (with the purpose of receiving MV) needed before MV is successfully administered.
• Secondary outcome D:
Analysis of context and evaluation of the different intervention messages.
• Secondary outcome E:
Cost/benefit analysis of verbal telephone messages versus SMS messages. The costs in terms of time spent (voice calls), SMS fees, and technical
setup will be evaluated against the observed behavior change.
• Secondary outcome F:
Reasons for nonvaccination. Qualitative study of the main reasons for noncompliance with the Expanded Program on Immunization, among
participants whose children have not received the MV before 13 months of age.
• Secondary outcome G:
Effect of collecting multiple phone numbers. Analysis of whether the number of phone numbers collected per participant influences the success
rate of the intervention.
• Secondary outcome H:
Qualitative evaluation of the participants’ perception of the intervention message and overall experience of the intervention.
Safety & Ethics
Ethical Considerations
One of the key challenges in relation to mHealth is the issue of
privacy and data security [23], especially when potentially
stigmatizing diseases or substance abuse could be disclosed if
family members or others see the text messages, or gain access
to the phone used for the intervention [24]. This issue becomes
all the more relevant since we have chosen to include mothers,
some of whom do not have their own phones, but only have
access to shared phones. However, it is our judgment that
vaccination reminders do not represent any risk of unwanted
disclosure. In addition, a recent study from Argentina concluded
that 96% of the study participants (pregnant women attending
antenatal care) responded that they would like to receive text
messages and phone calls [25]. We have chosen to include
participants who do not have their own private phones in an
attempt to avoid adding further to the digital divide (ie, social
inequality due to lack of access to and/or knowledge of
information and communication technology).
Another ethical consideration is how to embrace
illiteracy/multiple spoken languages without adding to cultural
divides or discrimination against certain population segments
or ethnic groups. Culture-specific wording of messages is also
important, in order to avoid unintended negative effects [26].
At the time of enrollment, trained health workers will describe
the study in detail to the potential participants, and assess their
understanding in order to obtain their informed consent. All
information will be available in Creole (the primary spoken
language of Bissau).
To avoid sending SMS reminders to participants who have died
or moved out of the study area, or those whose children have
died or received the vaccine ahead of schedule, follow-up will
JMIR Res Protoc 2016 | vol. 5 | iss. 3 | e158 | p.5http://www.researchprotocols.org/2016/3/e158/
(page number not for citation purposes)
Rossing et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
be done to the extent possible at the health facilities. It is likely
that some of these events will go unnoticed, potentially resulting
in inappropriate messages being sent. This problem does not
differ from current practices of the Health and Demographic
Surveillance System routines, in which families are occasionally
asked about deceased members of the household. The possibility
of receiving a message regarding a deceased child will
furthermore be explained during the informed consent phase.
Registration and Ethical Approvals
This project has obtained the approval of the ethical committee
of Guinea-Bissau as well as a guiding statement from the ethical
body Udlandsudvalget in Denmark. The project has also
registered with clinicaltrials.gov (reg.no. NCT02662595).
Data Management & Statistical Analysis
Data Management
The data will be collected using digital questionnaires and stored
in a protected database. The data will not be shared with people
or organizations outside of the Bandim Health Project, unless
proper authorizations are obtained from the ethical committee
in Guinea-Bissau. However, the collected data might be made
available to an external project group as part of ongoing
monitoring and evaluation efforts.
Sample Size Calculations
Current statistics indicate MV coverage of approximately 75%
at 12 months of age in the rural areas of Guinea-Bissau. Drawing
on experiences from other studies implementing SMS reminders
[13], we aim for an increase in MV coverage of 10 percentage
points. Using a significance level of 5% and 80% power, and a
hypothesized increased MV coverage to at least 85% in each
of the intervention arms (compared to the control arm), a total
of 810 children are needed (270 in each arm). Adjusting for
expected loss-to-follow-up between 15-20% (eg, outmigration,
death, children being vaccinated elsewhere), which is
comparable to other mHealth studies [27], we plan to enroll 990
study participants (330 in each arm).
The current median age of MVs given before 12 months of age
in rural Guinea-Bissau is approximately 295 days of age [7].
The age distribution is fairly normal, and in the following power
calculation we have used a normal approximation: with 270
children in each arm and an MV coverage of at least 75%, we
are able to detect a change of 7 days in median age (using a
significance level of 5% and 80% power).
Statistical Analysis
The main outcome of MV coverage at 12 months of age (366
days of age) will be calculated as percent who received MV at
the health centers, among all children enrolled. Furthermore,
coverage will also be calculated based on follow-up interviews
when children reach 13 months of age, among study participants
whose children did not receive the MV at the health centers.
The coverage (percentages) will be compared using
Mantel-Haenszel statistics stratified for health center for each
of the intervention groups (SMS and voice calls) compared with
the control group. The secondary outcome B (Textbox 1) of
timeliness of MVs will compare age distributions between
vaccinated children, among all children having received MVs
before 12 months of age (366 days), using linear regression
adjusted for health center. A statistical significance level of 5%
will be used. A subanalysis will stratify for study participants
having their own private mobile phone versus those using the
phone number of another community member. Due to the groups
being randomized, we do not expect baseline imbalances. In
the case that such trends do occur, we will be unable to rule out
other imbalances or unmeasured confounders. The main outcome
will therefore be the crude estimate. However, we will
investigate the impact of adjusting for unbalanced background
factors in sensitivity analyses. The study will be conducted and
reported in accordance with Consolidated Standards of
Reporting Trials guidelines [28].
Discussion
Possible Constraints
External threats to the project, such as strikes in the health
sector, shortages of measles vaccine, and other interventions in
the same region, will prompt ad-hoc decisions. Problems with
vaccine delivery to the vaccination sites will result in the
rescheduling of intervention messages (eg, the reminder
messages can be rescheduled until vaccine is restocked).
Dissemination of Results and Publication Policy
Articles are planned for each of the main study components.
The main article, concerning the second study component, will
contain a statistical analysis linking the effect the mHealth
intervention to health outcomes in terms of MV coverage and
timeliness. The primary author of the article will be Emil
Rossing, with the remaining core members of the project team
listed as contributing authors.
A second article will analyze the cost and effect of the mHealth
intervention, linking the intervention to vaccination coverage,
and add to the evidence base for mHealth interventions. In
addition to these articles, the findings of this study will be
presented to the National Ministry of Health in Guinea-Bissau,
which will also be included as much as possible during the
project implementation.
Limitations and Anticipated Problems
Several problems are anticipated in this study, including
technical obstacles such as an unstable cellphone network, and
low or no signal in some areas. In order to mitigate these issues,
extra attention will be given to delivery reports to ensure that
the text messages are delivered correctly. In addition, the impact
of network-related problems will be covered by the follow-up
questionnaire.
The project is also vulnerable to other interventions related to
the MVs that are being carried out within the study area, since
this could distort the findings of this study. To minimize this
risk, the study team will coordinate closely with the National
Ministry of Health in Guinea-Bissau.
By only enrolling participants who have access to mobile
telephones, there is a risk of potentially adding to social injustice
by focusing on a selected demographic with comparably better
access to resources, sometimes referred to as digital divide.
However, we have tried to mitigate this problem by defining
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access to a mobile telephone in the broadest sense possible, by
also including participants who will receive the reminder
message on the phone of their community’s health
communication agent. Such agents will be community residents
employed by the Ministry of Health as contact points to
disseminate information about health events, such as vaccination
campaigns. These agents will also help to mitigate the limitation
of study participants that do not speak Creole. However, the
fact that there are multiple spoken languages in the study area
still poses a limitation to the project.
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